JP2016518415A5 - - Google Patents

Download PDF

Info

Publication number
JP2016518415A5
JP2016518415A5 JP2016513120A JP2016513120A JP2016518415A5 JP 2016518415 A5 JP2016518415 A5 JP 2016518415A5 JP 2016513120 A JP2016513120 A JP 2016513120A JP 2016513120 A JP2016513120 A JP 2016513120A JP 2016518415 A5 JP2016518415 A5 JP 2016518415A5
Authority
JP
Japan
Prior art keywords
recipient
plasma
donor
blood
periodic basis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016513120A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016518415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/037496 external-priority patent/WO2014183033A2/en
Publication of JP2016518415A publication Critical patent/JP2016518415A/ja
Publication of JP2016518415A5 publication Critical patent/JP2016518415A5/ja
Pending legal-status Critical Current

Links

JP2016513120A 2013-10-21 2014-05-09 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法 Pending JP2016518415A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361893444P 2013-10-21 2013-10-21
US61/893,444 2013-10-21
PCT/US2014/037496 WO2014183033A2 (en) 2013-05-09 2014-05-09 Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019059259A Division JP2019112463A (ja) 2013-10-21 2019-03-26 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法

Publications (2)

Publication Number Publication Date
JP2016518415A JP2016518415A (ja) 2016-06-23
JP2016518415A5 true JP2016518415A5 (enExample) 2017-06-15

Family

ID=56142414

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016513120A Pending JP2016518415A (ja) 2013-10-21 2014-05-09 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法
JP2019059259A Pending JP2019112463A (ja) 2013-10-21 2019-03-26 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法
JP2021024199A Active JP7642278B2 (ja) 2013-10-21 2021-02-18 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019059259A Pending JP2019112463A (ja) 2013-10-21 2019-03-26 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法
JP2021024199A Active JP7642278B2 (ja) 2013-10-21 2021-02-18 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法

Country Status (1)

Country Link
JP (3) JP2016518415A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110743103A (zh) * 2019-10-25 2020-02-04 上海市同济医院 一种促进脊髓来源神经干细胞修复损伤的磁场干预装置及方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1427747B1 (en) * 2001-08-30 2012-04-11 ARCA biopharma, Inc. Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
US7790039B2 (en) * 2003-11-24 2010-09-07 Northwest Biotherapeutics, Inc. Tangential flow filtration devices and methods for stem cell enrichment
WO2005117696A2 (en) * 2004-05-27 2005-12-15 Parker Richard F Method and apparatus for generating a therapeutic magnetic field
US20060193839A1 (en) * 2005-02-28 2006-08-31 Donnie Rudd Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
JP2007105037A (ja) * 2005-09-16 2007-04-26 Univ Of Tokyo キメリズムを利用した幹細胞移植のための検査
KR101493474B1 (ko) * 2007-01-09 2015-02-16 클리브랜드 바이오랩스, 아이엔씨. 조혈 줄기 세포를 증가시키고 이동시키는 방법들

Similar Documents

Publication Publication Date Title
JP2016526531A5 (enExample)
US20230364201A1 (en) Pharmaceutical composition containing insulin-like growth factor-2 and use thereof
RU2015152860A (ru) Режим введения и составы для аденовирусов типа в
RU2016149316A (ru) Лечение ревматоидного артрита
JP2016501528A5 (enExample)
Jin et al. The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia
CN103142620A (zh) 一种熊果酸在抗肿瘤免疫中的用途
Wu et al. Critical roles of balanced innate lymphoid cell subsets in intestinal homeostasis, chronic inflammation, and Cancer
JP2016518415A5 (enExample)
JP2018522881A5 (enExample)
CN107132357B (zh) 一种逆转乙型肝炎病毒慢性感染的抗Tim-3抗体和α-galcer的组合及应用
JP2019031470A (ja) Ｎｋ細胞培養上清を含む抗腫瘍組成物およびその製造方法
CA3071983A1 (en) Treating and inhibiting leukemia with nk-92 cells
CN119776283B (zh) Car-t细胞培养方法及其在肿瘤治疗中的应用
Watcharenwong et al. Thymoma associated with neuromyelitis optica spectrum disorder: a case report
Kim et al. Vitamin C infusion for gastric acid aspiration-induced acute respiratory distress syndrome (ARDS)
Sakashita et al. Factors affecting autologous peripheral blood hematopoietic stem cell collections by large-volume leukapheresis: a single center experience
ACHARYA et al. Thrombocytopenia to reactive thrombocytosis in scrub typhus-the play of platelets
WO2024238387A1 (en) Method of treating alzheimer's disease with expanded natural killer cells
CN105534999A (zh) 一种用于治疗肿瘤的药物组合物及其应用
Schmidt et al. Transfusion‐Induced Immunomodulation
Miyoshi Various toxicities: case report
JP2023515502A (ja) Ｃｏｖｉｄ－１９を治療するための早期アポトーシス細胞の使用
WU et al. SAFETY OF IMMUNOSUPPRESSIVE REGIMEN WITH STEROIDS WITHDRAWAL WITHIN 24 HOURS POSTOPERATIVELY IN LIVER TRANSPLANTATION: 2904
Uryuhara et al. POTENTIALITY OF RITUXIMAB IN ADULT LIVING DONOR LIVER TRANSPLANTATION ACROSS ABO BARRIER: 2975